证券代码：002044 证券简称：美年健康 公告编号：2025-085 美年大健康产业控股股份有限公司 关于确认 2025 年 1-10 月日常关联交易执行情况及 预计 2026 年度日常关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、日常关联交易基本情况 （一）日常关联交易概述及审议情况 美年大健康产业控股股份有限公司（以下简称"公司"）于 2025 年 12 月 16 日召开第九届董事会独立董事专门会议第六次会议及第九届董事会第十六次（临 时）会议，审议通过《关于确认 2025 年 1-10 月日常关联交易执行情况及预计 2026 年度日常关联交易的议案》和《关于调整公司 2025 年度日常关联交易预计额度 的议案》。2025 年度，公司预计日常关联交易总额不超过人民币 115,060.00 万 元，2025 年 1-10 月，公司实际发生金额为人民币 77,042.40 万元。 根据业务发展及日常经营活动的需要，就 2026 年度公司及下属公司与公司 实际控制人俞熔先生控制的企业、Alibaba Group Holding Limit ...

证券代码：002044 证券简称：美年健康 公告编号：2025-086 美年大健康产业控股股份有限公司 关于公司及下属子公司申请融资额度并提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 本次被担保对象慈铭健康体检管理集团有限公司（以下简称"慈铭健康"）等 部分下属子公司的资产负债率超过 70%，请投资者充分关注担保风险。 本次担保不构成关联交易，本次担保尚需提交公司股东会审议。 一、本次综合授信额度及担保和反担保情况概述 （一）本次综合授信额度 根据美年大健康产业控股股份有限公司（以下简称"美年健康"或"公司"）经 营规划，为支持公司及下属子公司运营发展的融资需要，公司及所有合并报表范 围内的下属子公司拟向银行等金融机构申请 2026 年度融资额度不超过人民币 50 亿元。融资内容包括但不限于流动资金贷款、项目资金贷款、供应链融资、并购、 银行承兑汇票、保函、保理、融资租赁（包括但不限于售后回租）、固定资产贷 款等业务，在额度内循环使用。 （二）本次担保基本情况 公司及部分下属子公司 2026 年度拟为公司及合并报表范围内的子公司在 ...

证券代码：002044 证券简称：美年健康 公告编号：2025-084 美年大健康产业控股股份有限公司 关于调整公司 2025 年度日常关联交易预计额度的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、日常关联交易基本情况 （一）日常关联交易概述 美年大健康产业控股股份有限公司（以下简称"公司"）于 2024 年 12 月 13 日召开第九届董事会独立董事专门会议第二次会议、第九届董事会第五次（临时） 会议及 2024 年 12 月 30 日召开 2024 年第六次临时股东大会，审议通过《关于确 认2024年1-10月日常关联交易执行情况及预计2025年度日常关联交易的议案》， 同意公司预计 2025 年度日常关联交易总金额不超过人民币 90,560.00 万元，具体 内容详见公司于 2024 年 12 月 14 日在巨潮资讯网（www.cninfo.com.cn）披露的 《关于确认 2024 年 1-10 月日常关联交易执行情况及预计 2025 年度日常关联交 易的公告》（公告编号：2024-112）。 公司于 2025 年 7 月 11 日召开第 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 重要提示： 美年大健康产业控股股份有限公司（以下简称"公司"或"美年健康"）2026 年第一次临时股东会现场会议的召开地点为上海市静安区灵石路 697 号健康 智谷 9 号楼三楼公司会议室，敬请投资者特别留意。 根据公司于 2025 年 12 月 16 日召开的第九届董事会第十六次（临时）会 议，定于 2026 年 1 月 6 日召开公司 2026 年第一次临时股东会，本次股东会将 采用股东现场记名投票与网络投票表决相结合的方式召开，现就本次股东会 的有关事宜通知如下： 一、召开会议的基本情况 1.股东会届次：2026 年第一次临时股东会 证券代码：002044 证券简称：美年健康 公告编号：2025-087 美年大健康产业控股股份有限公司 关于召开 2026 年第一次临时股东会的通知 2.股东会的召集人：董事会 3.本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易 所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上 市公司规范运作》等法律、行政法规、部门规章、规范性文件及《公 ...

证券代码：002044 证券简称：美年健康 公告编号：2025-083 美年大健康产业控股股份有限公司 第九届董事会第十六次（临时）会议决议公告 1.审议并通过《关于调整公司 2025 年度日常关联交易预计额度的议案》 表决结果：赞成 6 票，反对 0 票，弃权 0 票。 公司董事俞熔先生、郭美玲女士、王晓军先生与本议案存在关联关系或利益 关系，为公司关联董事，均已回避表决。其他非关联董事参与本议案的表决。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 美年大健康产业控股股份有限公司（以下简称"公司"）第九届董事会第十六 次（临时）会议于 2025 年 12 月 11 日以电子发送等形式发出会议通知，会议于 2025 年 12 月 16 日上午 10 时以通讯方式召开。应出席本次会议的董事为 9 名，实际出 席会议的董事为 9 名。会议由公司董事长俞熔先生主持，公司高级管理人员列席 了会议。本次会议的出席人数、召开表决程序、议事内容均符合《中华人民共和 国公司法》《公司章程》等有关规定。 二、董事会会议审议情况 本次增加 2025 年 ...

港仔机器人主动健管团队利用自研算法重构了中医古籍、现代权威教材及百万级医学问答对，构建了高质量训练数据集，采用指令微调技术，成功将异构的 中医理论体系深度内化为模型参数，赋予了HKR_TCM_HW_v1 强大的中医综合能力。 HKR_TCM_HW_v1 不仅实现了中医大模型技术的新突破，更为中医主动健康管理提供了全新视角。港仔机器人主动健管团队以HKR_TCM_HW_v1为核 心，打造了中医养生超级智能体，作为港仔机器人 AI 主动健康中心全流程服务的核心引擎，为用户提供中医健康分析、中医健康调控方案生成等一站式服 务。 该榜单的支持单位还包括上海中医药大学、中国中医科学院。MedBench平台全方位考察了大模型中医综合能力，紧扣中医基础、经典理解、临床诊疗、中 药方剂、针灸推拿五大核心维度，以多维度试题及真实临床病案场景设计考题，力求精准评估模型的中医专业素养与实战应用水平。 AI 主动健康中心，由香港本土首家具身智能机器人企业港仔机器人与国内预防医学领军企业美年健康（002044）联合研发，是新一代智能健康管理解决方 案的标杆之作。 智通财经APP了解到，近日，由上海人工智能实验室（人工智能领域国家级研发 ...

证券日报网讯12月15日，美年健康（002044）在互动平台回答投资者提问时表示，公司将根据监管要求 及时履行信息披露义务。 ...

Core Viewpoint - The conference aims to promote the "Healthy China 2030" strategy by enhancing health management responsibilities and achieving shared health goals through innovative practices in chronic disease prevention and workplace health management [1] Group 1: Conference Overview - The conference was held in Beijing from December 11 to 12, 2025, organized by the Chinese Medical Association and the Chronic Non-communicable Disease Prevention and Control Center [1] - Experts and representatives from various organizations, including Meinian Health and Ciming Group, gathered to discuss new pathways for corporate health management [1] Group 2: Initiatives and Actions - The "Three Strong Actions" initiative was launched, focusing on collaborative research and high-quality workplace health management [6][7] - Meinian Health's president highlighted the importance of employee health, stating that a 4% increase in employee health can lead to a 1% rise in corporate profits [7] - 83% of companies have developed health management strategies, and 62% plan to increase health budgets, with 90% utilizing digital health management tools [7] Group 3: Digital Health Management - Meinian Health has implemented an "All in AI" strategy, focusing on digitalization and AI in health management, aiming to transform health data into valuable assets [8][9] - The company has developed various innovative health management services, including cognitive impairment screening and AI-assisted diagnostics [9] Group 4: Future Directions - Meinian Health plans to enhance integration between health checks, management, and commercial insurance, focusing on early screening for major diseases [10] - The conference emphasized the need for collaboration among government, medical institutions, and enterprises to build a comprehensive health management ecosystem [14][16] Group 5: Action Initiatives - The "Implementing Health Priority Strategy, Sharing Health Responsibility" initiative was launched, focusing on enhancing corporate health culture and improving health management capabilities [20][22] - The initiative aims to promote high-quality occupational health protection and digital health management services [22]

Core Insights - The "2025 Fifth China Health Industry Development and Rehabilitation Service Conference" was successfully held in Beijing, focusing on integrating resources across the health industry and exploring development paths under the theme "Intelligent Leadership for a Healthy Future" [1] Group 1: Industry Trends and Innovations - The conference featured high-level roundtable discussions on cutting-edge topics such as innovative drugs, brain-machine interfaces, AI in healthcare, and the transformation of traditional Chinese medicine [1] - A series of innovative case studies were released, showcasing advancements in areas like ESG, innovative drugs, biomedicine, AI healthcare, and social psychological services, highlighting the vitality and innovation within the health sector [1] Group 2: Company Highlights - **Jingtai Holdings** utilizes "AI + Robotics + Data" to accelerate drug development, having collaborated with major pharmaceutical companies and significantly expedited the market entry of Pfizer's COVID-19 oral drug Paxlovid by six months [3] - **Meinian Health** leverages AI technology for precise early screening and health management, continuously launching specialized products to meet diverse public health management needs [4] - **Dean Diagnostics** has developed an AI product matrix that enhances medical scene intelligence, achieving comprehensive coverage from hospitals to personal health management [5] - **Yingkang Life** integrates AI deeply into the entire medical service process, significantly improving medical capabilities and operational efficiency through its AI-driven platforms [6][7] - **New Mile Health Technology** is advancing a smart healthcare system that combines online and offline services, enhancing the digital landscape of managed healthcare [8] - **Airdoc** focuses on retinal AI imaging technology for chronic disease early screening and management, having provided diagnostic solutions to over 30 million people [9] - **Aidikang** employs AI-assisted imaging to enhance detection efficiency, achieving a performance rate of 6-7 times that of manual processes in key medical fields [10] - **Yidu Technology** has introduced the "Doctor Copilot" AI platform, which integrates seamlessly into clinical workflows, significantly enhancing the efficiency of healthcare services [11] - **Deepwise Medical** offers multi-modal AI solutions to various healthcare institutions, supporting high-quality development across the medical sector [12] - **Huadensen Bio** focuses on "precision diagnosis" through liquid biopsy technology, utilizing AI to improve the efficiency and accuracy of CTC detection [14]

Core Insights - The summit held by UN Women on December 5 focuses on how gender equality can become a new engine for corporate growth, marking the 30th anniversary of the Beijing Declaration and the 15th anniversary of the Women's Empowerment Principles (WEPs) [1] Group 1: Gender Equality as a Business Driver - Promoting gender equality is not only a social welfare issue but also a direct driver for companies to enhance profitability, improve talent retention, and optimize ESG performance. Companies with stronger gender inclusivity have a 63% higher likelihood of increased profitability and a 60% higher chance of improved talent retention [3] - The discussion on reshaping leadership for long-term competitiveness and sustainable development highlighted the need for leaders to adapt to rapid technological changes and external uncertainties [3] Group 2: Leadership in Crisis - In the current complex macro environment, the role of female leadership has evolved, with more women taking on CEO positions during economic downturns. This shift reflects a belief that women possess crisis management skills [5][6] - The concept of "Glass Cliff" suggests that women are often appointed to leadership roles during high-risk situations, which can lead to structural biases against them if they fail [6] Group 3: Interactive Leadership - The importance of "hands-on" leadership is emphasized, where leaders engage directly with their teams rather than relying solely on positional authority. This interactive approach fosters shared goals and collective responsibility [9] - Female leaders are noted for their ability to create inclusive visions that allow team members to grow while achieving organizational missions, which is crucial in today's collaborative business environment [9] Group 4: Bridging Cognitive Gaps - Effective leadership challenges often lie in bridging cognitive gaps among diverse team members. Empathy, rather than persuasion, is key to achieving this [10] - A case study illustrates how a leader successfully navigated cross-cultural management challenges by actively learning and engaging with team members, thereby building a common knowledge base and fostering collaboration [10][11] Group 5: Systemic Integration of Women's Leadership - When companies systematically integrate the advantages of female leadership into their strategies and operations, gender equality transforms from a social responsibility into a business engine that drives innovation, resilience, and long-term sustainable development [13]